ES2106319T3 - Uso de lactoferrina en la fabricacion de un medicamento para el tratamiento del reumatismo. - Google Patents

Uso de lactoferrina en la fabricacion de un medicamento para el tratamiento del reumatismo.

Info

Publication number
ES2106319T3
ES2106319T3 ES93901738T ES93901738T ES2106319T3 ES 2106319 T3 ES2106319 T3 ES 2106319T3 ES 93901738 T ES93901738 T ES 93901738T ES 93901738 T ES93901738 T ES 93901738T ES 2106319 T3 ES2106319 T3 ES 2106319T3
Authority
ES
Spain
Prior art keywords
rheumatism
treatment
lactoferrin
manufacture
medicinal product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93901738T
Other languages
English (en)
Inventor
Mitsushi Hikida
Masaaki Hayashi
Michel Francois Degre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Serae Laboratoires SA
Original Assignee
Bio Serae Laboratoires SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11507338&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2106319(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bio Serae Laboratoires SA filed Critical Bio Serae Laboratoires SA
Application granted granted Critical
Publication of ES2106319T3 publication Critical patent/ES2106319T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Abstract

LA PRESENTE INVENCION CONCIERNE A UN AGENTE TERAPEUTICO PARA EL REUMATISMO QUE CONTIENE LACTOFERRINA COMO INGREDIENTE ACTIVO. DICHO AGENTE TERAPEUTICO MUESTRA UN EXCELENTE EFECTO INHIBIDOR CONTRA LA ACTIVIDAD DE LA COLAGENASA Y ES UTIL PARA EL TRATAMIENTO DEL REUMATISMO.
ES93901738T 1992-01-08 1993-01-06 Uso de lactoferrina en la fabricacion de un medicamento para el tratamiento del reumatismo. Expired - Lifetime ES2106319T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP00164892A JP3184923B2 (ja) 1992-01-08 1992-01-08 抗リウマチ剤

Publications (1)

Publication Number Publication Date
ES2106319T3 true ES2106319T3 (es) 1997-11-01

Family

ID=11507338

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93901738T Expired - Lifetime ES2106319T3 (es) 1992-01-08 1993-01-06 Uso de lactoferrina en la fabricacion de un medicamento para el tratamiento del reumatismo.

Country Status (5)

Country Link
EP (1) EP0620737B1 (es)
JP (1) JP3184923B2 (es)
DE (1) DE69313261T2 (es)
ES (1) ES2106319T3 (es)
WO (1) WO1993013790A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998044940A1 (en) * 1997-04-10 1998-10-15 Agennix, Inc. Use of lactoferin in the treatment of allergen induced disorders
JP4291506B2 (ja) 1997-08-22 2009-07-08 デカ・プロダクツ・リミテッド・パートナーシップ 静脈薬剤混合・射出用システム、方法及びカセット
AU5997801A (en) * 2000-05-15 2001-11-26 Canadian Inovatech, Inc. Compositions for the preservation of collagen and elastin
JP4592041B2 (ja) * 2000-11-24 2010-12-01 株式会社Ｎｒｌファーマ 生活の質を改善する新規食品の製造法および用途
EP1477182A4 (en) 2002-01-21 2009-05-27 Nrl Pharma Inc NEW ANALGETICS
WO2003094952A1 (en) 2002-05-10 2003-11-20 Agennix Incorporated Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
WO2005046571A2 (en) 2003-06-06 2005-05-26 Agennix Incorporated Lactoferrin as an adjuvant in cancer vaccines
ES2301152T3 (es) * 2005-03-15 2008-06-16 Campina Nederland Holding B.V. Uso dermatologico de proteinas lacteas.
JP2008189637A (ja) * 2007-02-08 2008-08-21 Snow Brand Milk Prod Co Ltd 自己免疫疾患予防剤
HRPK20110080B3 (hr) 2011-02-02 2014-01-03 Zdravko MAUKO Pripravak za lijeäśenje koštanih poremeä†aja i poremeä†aja zglobova

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3661339D1 (en) * 1985-01-18 1989-01-12 Gauri Kailash Kumar Protein hydrolysates, production process and drugs containing th em

Also Published As

Publication number Publication date
DE69313261D1 (de) 1997-09-25
EP0620737A1 (en) 1994-10-26
JP3184923B2 (ja) 2001-07-09
JPH05186368A (ja) 1993-07-27
WO1993013790A1 (en) 1993-07-22
EP0620737B1 (en) 1997-08-20
DE69313261T2 (de) 1998-03-26

Similar Documents

Publication Publication Date Title
ES2178048T3 (es) Uso de rifaximina como medicamento para el tratamiento de diarrea por criptosporidiosis.
ES2136739T3 (es) Copolimeros elastomeros termoplasticos injertados de silicona y composiciones para el cuidado del cabello y de la piel que los contienen.
ES2139132T3 (es) Composiciones farmaceuticas activas en la terapia de desordenes del sueño.
ES2145143T3 (es) Copolimeros elastomericos termoplasticos y composiciones que los contienen para el cuidado del cabello y de la piel.
SE8503664L (sv) Ett system for tillforsel av lekemedel
ES2145836T3 (es) Copolimeros elastomericos termoplasticos injertados de silicona, y composiciones que los contienen para el cuidado del pelo y la piel.
ES2157601T3 (es) Uso de agentes anti-microtubulos para tratar o prevenir la esclerosis multiple.
ATE429904T1 (de) Topisch anwendbare arzneipräparate und verfahren zur behandlung
GR77254B (es)
ES2166783T3 (es) Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii.
ES2082198T3 (es) Inhibidores de esteroide-sulfatasa.
ATE121627T1 (de) Verminderung oder verhütung der von arzneimitteln verursachten hautreizung.
ES2116642T3 (es) Composicion farmaceutica para tratar la osteoporosis que contiene xantohumol.
ES2106319T3 (es) Uso de lactoferrina en la fabricacion de un medicamento para el tratamiento del reumatismo.
ES2061989T3 (es) Uso de esteres alquilicos del acido piroglutamico para la fabricacion de un medicamento para el tratamiento de la ictiosis.
MX9602973A (es) Uso de un antagonista de bradiquinina en una composicion, cosmetica, farmaceutica o dermatologica y la composicion obtenida.
ES2149279T3 (es) Sistema terapeutico para el tratamiento de la psoriasis.
ES2125356T3 (es) Empleo de leflunomida para la inhibicion de interleuquina 8.
ES2177849T3 (es) Preparado farmaceutico, que contiene 2-fenil-1,2-benzoisoselenazol-3(2h)-ona, para el tratamiento de la enfermedad de alzheimer.
ES2159357T3 (es) Derivados terpenoides (sarcodictinas) utiles como agentes antitumorales.
SE8101374L (sv) Kompositioner innehallande n,n-dietyl-m-toluamid
ES2042818T3 (es) Agente terapeutico para la trombocitopenia.
AR010432A1 (es) Composiciones farmaceuticas que contienen acido ricinoleico y su uso para la terapia antiinflamatoria y analgesica
MD1484F2 (ro) Aplicare a dimeticonei în calitate de ingredient activ în compoziţie farmaceutică pentru tratamentul constipaţiilor şi compoziţie farmaceutică conţinând dimeticonă
ES2165034T3 (es) Agentes terapeuticos que contienen ebselen contra el asma.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 620737

Country of ref document: ES